复星医药-持续创新 乐享健康
上海复星医药集团（“复星医药”，股票代码：600196.sh，02196.hk）成立于1994 年，是一家植根中国、创新驱动的全球化医药健康产业集团，直接运营的业务包括制药、医疗器械与医学诊断、医疗健康服务，并通过参股国药控股覆盖到医药商业领域。
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 14.752 |
| 2025-03 | 19.354 |
| 2025-04 | 25.717 |
| 2025-05 | 27.544 |
| Source | Traffic Share |
|---|---|
| search | 48.98% |
| direct | 43.85% |
| referrals | 5.48% |
| social | 1.06% |
| paid referrals | 0.50% |
| 0.13% |
| Region | Percentage |
|---|---|
| China | 73.04% |
| India | 8.47% |
| United States | 8.25% |
| Hong Kong | 2.03% |
| KR | 1.88% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| 复星医药 | 103 | 1,030 | $0.00 |
| fosun pharma | 188 | 1,880 | $0.00 |
| 中国 复必泰 | 3 | 30 | $0.00 |
| 复兴医药 | 14 | 140 | $0.00 |
| 上海 礼来 骆希 | 2 | 20 | $0.00 |